T1	Participants 37 71	severe atopic dermatitis in adults
T2	Participants 192 245	59 patients with moderate to severe atopic dermatitis
T3	Participants 320 360	Forty-seven patients completed the study
T4	Participants 362 411	No difference in efficacy was seen among patients
